What is it about?

To evaluate whether proton MR spectroscopy and perfusion MRI are able to increase diagnostic accuracy (DA) in the follow up of patients with brain gliomas, identifying the progression of disease before it becomes evident in the standard MRI; also to evaluate which of the two techniques has the best diagnostic accuracy.

Featured Image

Why is it important?

Our experience shows that, CBV alone has a huge impact on the evaluation of the tumor grading at the first observation , but a more accurate classification of the tumor will have the combination of all imaging parameters (standard MRI, DWI, Spectroscopy and Perfusion). In according to literature, our study confirms that the use of MR spectroscopy and perfusion improves the correct diagnosis compared to standard MRI, and can anticipate the evidence of tumor progression during follow-ups.

Perspectives

I hope this article may be a cue for other brain tumor studies to improve the life expectancy of these patients.

Monica Anselmi

Read the Original

This page is a summary of: Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience, The Neuroradiology Journal, January 2017, SAGE Publications,
DOI: 10.1177/1971400916688354.
You can read the full text:

Read

Contributors

The following have contributed to this page